COVID-19:  FDA Issues Emergency Use Authorization for Hemolung RAS
ALung is committed to the safety and support of health care professionals, patients, and employees in the treatment of COVID-19.  The following is ALung’s response to the COVID-19 pandemic in the United States.

 

First Hemolung RAS Emergency Use Patients in 2014 and 2015

 

(2014) First US Patient Supported with the Hemolung RAS at UPMC in Pittsburgh

(2015) University of Maryland uses Hemolung RAS